Extent and cost of inappropriate use of tumour markers in patients with pulmonary disease: a multicentre retrospective study in Shanghai, China
Sign Up to like & getrecommendations! Published in 2018 at "BMJ Open"
DOI: 10.1136/bmjopen-2017-019051
Abstract: Objectives The currently implemented healthcare reform in China requires substantial capital investment. Although overtreatment results in serious waste, inappropriate laboratory use is widespread, and overuse of tumour markers (TMs) has attracted increasing attention. Design Retrospective… read more here.
Keywords: disease; tumour markers; inappropriate use; pulmonary disease ... See more keywords
National survey on internal quality control for tumour markers in clinical laboratories in China
Sign Up to like & getrecommendations! Published in 2018 at "Biochemia Medica"
DOI: 10.11613/bm.2018.020702
Abstract: Introduction This survey was initiated to obtain knowledge on the current situation of internal quality control (IQC) practice for tumour markers (TMs) in China. Additionally, we tried to acquire the most appropriate quality specifications. Materials… read more here.
Keywords: quality; survey; tumour markers; internal quality ... See more keywords
Evaluation of two strategies for the interpretation of tumour markers in pleural effusions
Sign Up to like & getrecommendations! Published in 2017 at "Respiratory Research"
DOI: 10.1186/s12931-017-0582-1
Abstract: BackgroundPleural effusions present a diagnostic challenge. Approximately 20% are associated with cancer and some 50% require invasive procedures to perform diagnosis. Determination of tumour markers may help to identify patients with malignant effusions. Two strategies… read more here.
Keywords: evaluation two; two strategies; benign biomarkers; tumour markers ... See more keywords